Renaissance Technologies (RenTech)'s KYTX Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 367,492 shares of Kyverna Therapeutics, Inc. (KYTX) worth $3.17 M, representing 0.00% of the portfolio. First purchased in 2024-Q4, this short-term holding has been held for 6 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained this position in KYTX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 189,593 shares. Largest reduction occurred in Q2 2025, reducing 2,541 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Kyverna Therapeutics (KYTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Kyverna Therapeutics (KYTX) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +189,593 | Add 106.57% | 367,492 | $8.63 |
| Q4 2025 | +13,285 | Add 8.07% | 177,899 | $9.40 |
| Q3 2025 | +42,197 | Add 34.47% | 164,614 | $6.00 |
| Q2 2025 | -2,541 | Reduce 2.03% | 122,417 | $3.07 |
| Q1 2025 | +80,258 | Add 179.55% | 124,958 | $1.93 |
| Q4 2024 | +44,700 | New Buy | 44,700 | $3.74 |
Renaissance Technologies (RenTech)'s Kyverna Therapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased Kyverna Therapeutics, Inc. (KYTX) in Q4 2024, acquiring 44,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Kyverna Therapeutics, Inc. (KYTX) for 6 quarters since Q4 2024.
Renaissance Technologies (RenTech)'s largest addition to Kyverna Therapeutics, Inc. (KYTX) was in Q1 2026, adding 367,492 shares worth $3.17 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 367,492 shares of Kyverna Therapeutics, Inc. (KYTX), valued at approximately $3.17 M.
As of the Q1 2026 filing, Kyverna Therapeutics, Inc. (KYTX) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Kyverna Therapeutics, Inc. (KYTX) was 367,492 shares, as reported at the end of Q1 2026.